It has also been shown that modern biologics such as TNF inhibitors may increase the risk of septic arthritis in rheumatoid arthritis (RA) patients compared to patients receiving conventional disease-modifying antirheumatic drugs (DMARDs; Galloway et al., 2011). Here, TNF is linked to bacterial arthritis.